Skip to main content

Diabetes, Type 2 News (Page 3)

Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2

Preoperative SGLT2 Inhibitor Users Have Increased Risk for Postoperative Euglycemic Ketoacidosis

TUESDAY, May 13, 2025 – Patients using sodium-glucose cotransporter 2 inhibitors (SGLT2i) preoperatively have a slightly increased risk for postoperative euglycemic ketoacidosis (eKA) but a lower...

GLP-1 Receptor Agonists Reduce Alcohol Intake in Patients Treated for Obesity

MONDAY, May 12, 2025 – Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are tied to a reduction in alcohol intake, according to a research letter recently published in Diabetes, Obesity and...

Hyperglycemia, Insulin Resistance in Teens Linked to Worsening Cardiac Damage at Age 24

FRIDAY, May 9, 2025 – Adolescent hyperglycemia and worsening insulin resistance (IR) are associated with an increased risk for worsening structural and functional cardiac damage, according to a...

Too Much Cinnamon May Interfere With Some Medications, Study Shows

MONDAY, May 5, 2025 — Consuming too much cinnamon might affect how your body absorbs some medications, new research shows. The study — published in the June issue of the journal Food Chemistry: Mol...

High Blood Pressure, Diabetes More Fatal For Men

FRIDAY, May 2, 2025 – Men are more likely than women to die from high blood pressure, diabetes and HIV/AIDS, after shrugging off medical care for the conditions, a new study says. These differences...

Sodium-Glucose Cotransporter 2 Inhibitors Increase Risk for Falls in Patients With Diabetes

WEDNESDAY, April 30, 2025 – Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent risk factor for falls in people with type 2 diabetes, according to a study published online March...

Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists

WEDNESDAY, April 30, 2025 – Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2 inhibitors (SGLT2is) and...

Umbilical Cord Could Contain Clues For Child's Future Health

FRIDAY, April 25, 2025 – Doctors might be able to predict a newborn's long-term health outlook, by analyzing their umbilical cord blood, a new study says. Genetic clues found in cord blood can offer...

FDA and Novo Nordisk Alert Consumers to Counterfeit Ozempic

MONDAY, April 21, 2025 – The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout for counterfeit Ozempic (semaglutide) and to...

Pregnancy Complications Affect Future Heart Health

FRIDAY, April 18, 2025 – Complications during pregnancy can mean a woman’s future heart health is at risk, particularly if she is overweight or obese, a new study says. Women who are carrying excess ...

First Weight-Loss Pill From Lilly, Orforglipron, Shows Promising Results

FRIDAY, April 18, 2025 — A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug, orforglipron, helped people w...

GLP-1 RAs, SGLT2 Inhibitors May Reduce Risk for Alzheimer Disease, Dementia in T2DM

THURSDAY, April 17, 2025 – Both glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) are associated with a reduced risk for Alzheimer disease...

Certain Combinations of Food Additives May Increase Risk for Type 2 Diabetes

WEDNESDAY, April 16, 2025 – Two widely consumed food additive mixtures may increase type 2 diabetes incidence, according to a study published online April 8 in PLOS Medicine. Marie Payen de la...

Adverse Events From Semaglutide Seen in the ED Usually GI-Related

TUESDAY, April 15, 2025 – The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal effects, according to a...

Tirzepatide Dispensations Increased Rapidly After Approval

TUESDAY, April 15, 2025 – After approval, tirzepatide dispensations increased markedly among adults with type 2 diabetes prescribed glucose-lowering medications (GLMs) and among adults without...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Diabetes Mellitus

Related drug support groups

metformin, Ozempic, Victoza, Mounjaro, Lantus, semaglutide, Trulicity, glipizide, Rybelsus, view more... Jardiance, liraglutide, tirzepatide, Lantus Solostar, Humalog, Farxiga, Novolog, Janumet, insulin glargine, Januvia, Bydureon, insulin lispro, Tresiba, dulaglutide, Levemir, insulin degludec, Invokana, glimepiride, Glucophage, Humulin N